The Canadian Clinical Drug Data Set April 2025 release is now available for access and implementation on the Terminology Server and Terminology Gateway. Learn More >

Important Update: We are pleased to announce significant enhancements to our FHIR Terminology Server, offering more seamless and standards-based access to terminology content for healthcare data exchange. Discover the new features and upcoming changes to our Terminology Gateway. Learn More >

Share this page:

file Important Recommendations from LOINC for SARS-CoV-2 Codes

  • Posts: 229
5 years 1 day ago - 5 years 1 day ago #5855 by Linda Monico
Regardless of the LOINC code that is currently being used for SARS CoV-2 , LOINC is strongly recommending that details about the specimen and the test kit along with the primary result be reported.

Specimen details would ideally be reported using the HL7 SPM segment if using v2.5.1 or higher, OBR-15 if using v2.3.x, or the FHIR Specimen resource. If none of these are supported, specimen details can be sent as a separate observation result using LOINC 66746-9 Specimen type.

The test kit name and/or unique identifier would ideally be reported in OBX-17 and OBX-18, respectively. If this is not an option, test kit details can be sent as separate observation results using LOINC 67099-2 Vendor device name and/or 74711-3 Unique device identifier.

If there are any questions, please let us know and we can liaise with LOINC team at RI.
Last edit: 5 years 1 day ago by Linda Monico.

Please Log in or Create an account to join the conversation.

InfoCentral logo

Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.